Overview

Global Veterinary Vaccines Market is estimated to value over USD 4.5 billion by 2026 end and register a CAGR of over 13% during the forecast period 2019 to 2026.

 

Rising incidences of livestock epidemics, increasing population of livestock and rising prevalence of zoonotic diseases are steering the global veterinary vaccines market growth. Rising awareness with regards to the commercial vaccines is responsible for the increasing adoption worldwide.

This market is one of the lucrative alternatives of investments seeking attention and investments from both non-government and government key players. The shifting emphasis on healthy animal husbandry and an increasing number of pet owners are other important factors boosting the market proliferation. The intervention of the government in channel distribution whereas, it is affecting the overall profits incurred by the manufacturers of the veterinary vaccines.

Attenuated vaccines segment dominated the market owing to advantages, for instance, enhanced long-term prevention and improved effectivity. Cattle vaccinations held the largest global veterinary vaccines market share owing to the rise in the insistence for safe and effective animal products. The companion animal vaccines are currently proliferating due to an increase in the number of pet ownerships across the world. The North American region subjugated the market in 2018. Rising animal product commercialization and increasing awareness regarding the health of animals are prime reasons for the region’s domination over the forecast period. The Asia Pacific region is predicted to exhibit rapid augmentation during the forecast timeframe due to faster adoption of animal vaccines for better animal health and high-quality food products.

 

Key market players included in the global veterinary vaccines industry are Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Ceva, Virbac, Vetoqunol, Phibro Animal Health, Hester, Hipra, Biologika, Biogenesis Bago, Tianjin Ringpu, China Animal Husbandry, Jinyu Bio-Technology.

 

Global Veterinary Vaccines Market Segmentation:

By Type

• Porcine Vaccines 
• Poultry Vaccines 
• Livestock Vaccines 

- Bovine Vaccines

- Small Ruminant Vaccines

• Companion Animal Vaccines 

- Canine Vaccines

- Feline Vaccines

• Aquaculture Vaccines 
• Other Animal Vaccines 

By Disease

• Porcine 
• Poultry 
• Livestock 

- Bovine

- Small Ruminants

• Companion Animals 

- Canine

- Feline

• Aquaculture 

By Technology

• Live Attenuated Vaccines
• Inactivated Vaccines 
• Toxoid Vaccines 
• Recombinant Vaccines 
• Other Vaccines 

By Region

• Europe
• North America
• Asia Pacific
• Rest of the World

 

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

 

Objectives of the Study:

• To provide with an exhaustive analysis on the global veterinary vaccines market by type, by disease, by technology and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents

1 Introduction 

1.1 Objectives of the Study 

1.2 Veterinary Vaccines Market Definition 

1.3 Veterinary Vaccines Market Scope 

        1.3.1 Markets Covered

        1.3.2 Years Considered for the Study

1.4 Currency 

1.5 Limitations 

1.6 Stakeholders 

 

2 Research Methodology 

2.1 Research Data 

        2.1.1 Secondary Data

                 2.1.1.1 Key Data From Secondary Sources

        2.1.2 Primary Data

                 2.1.2.1 Key Data From Primary Sources

                 2.1.2.2 Breakdown of Primary Interviews

                 2.1.2.3 Key Industry Insights

2.2 Veterinary Vaccines Market Size Estimation 

2.3 Market Breakdown and Data Triangulation 

        2.3.1 Research Assumptions

 

3 Executive Summary 

 

4 Premium Insights 

4.1 Global Market Overview 

4.2 APAC Market, By Technology and Region 

4.3 Poultry Animal Market, By Disease 

4.4 Veterinary Vaccines Market By Geography 

 

5 Overview 

5.1 Introduction 

5.2 Veterinary Vaccines Market Dynamics 

        5.2.1 Drivers

                 5.2.1.1 Growth in Livestock Population and Repeated Outbreaks of Livestock Diseases

                 5.2.1.2 Increasing Adoption of Companion Animals

                 5.2.1.3 Rising Incidence of Zoonotic Diseases

                 5.2.1.4 Initiatives By Various Government Agencies, Animal Associations, and Leading Players

                 5.2.1.5 Introduction of New Types of Vaccines

        5.2.2 Restraints

                 5.2.2.1 High Storage Costs for Vaccines

        5.2.3 Opportunities

                 5.2.3.1 Technological Advancements

                 5.2.3.2 Growing Awareness of Animal Health in Emerging Economies

        5.2.4 Challenge

                 5.2.4.1 Inadequate Surveillance and Reporting Systems

 

6 By Type 

6.1 Introduction 

6.2 Porcine Vaccines 

6.3 Poultry Vaccines 

6.4 Livestock Vaccines 

        6.4.1 Bovine Vaccines

        6.4.2 Small Ruminant Vaccines

6.5 Companion Animal Vaccines 

        6.5.1 Canine Vaccines

        6.5.2 Feline Vaccines

6.6 Aquaculture Vaccines 

6.7 Other Animal Vaccines 

 

7 By Disease 

7.1 Introduction 

7.2 Porcine 

7.3 Poultry 

7.4 Livestock 

        7.4.1 Bovine

        7.4.2 Small Ruminants

7.5 Companion Animals 

        7.5.1 Canine

        7.5.2 Feline

7.6 Aquaculture 

 

8 By Technology 

8.1 Introduction 

8.2 Live Attenuated Vaccines 

8.3 Inactivated Vaccines 

8.4 Toxoid Vaccines 

8.5 Recombinant Vaccines 

8.6 Other Vaccines 

 

9 By Region 

9.1 Introduction 

9.2 Europe 

9.3 North America 

        9.3.1 US

        9.3.2 Canada

9.4 Asia Pacific (APAC) 

        9.4.1 China

        9.4.2 Thailand

        9.4.3 India

        9.4.4 Rest of APAC

9.5 Rest of the World 

 

10 Competitive Landscape 

  10.1 Introduction 

  10.2 Veterinary Vaccines Market Ranking Analysis 

  10.3 Competitive Leadership Mapping 

          10.3.1 Visionary Leaders

          10.3.2 Innovators

          10.3.3 Dynamic Differentiators

          10.3.4 Emerging Companies

  10.4 Competitive Benchmarking 

          10.4.1 Strength of Product Portfolio (25 Players)

          10.4.2 Business Strategy Excellence (25 Players)

 

11 Company Profiles 

  11.1 Zoetis 

          11.1.1 Business Overview

          11.1.2 Strength of Product Portfolio

          11.1.3 Business Strategy Excellence

          11.1.4 Recent Developments

  11.2 Merck Animal Health 

          11.2.1 Business Overview

          11.2.2 Strength of Product Portfolio

          11.2.3 Business Strategy Excellence

          11.2.4 Recent Developments

  11.3 Boehringer Ingelheim 

          11.3.1 Business Overview

          11.3.2 Strength of Product Portfolio

          11.3.3 Business Strategy Excellence

          11.3.4 Recent Developments

  11.4 Elanco 

          11.4.1 Business Overview

          11.4.2 Strength of Product Portfolio

          11.4.3 Business Strategy Excellence

          11.4.4 Recent Developments

  11.5 Ceva 

          11.5.1 Business Overview

          11.5.2 Strength of Product Portfolio

          11.5.3 Business Strategy Excellence

          11.5.4 Recent Developments

  11.6 Virbac 

          11.6.1 Business Overview

          11.6.2 Strength of Product Portfolio

          11.6.3 Business Strategy Excellence

          11.6.4 Recent Developments

  11.7 Vetoquinol 

          11.7.1 Business Overview

          11.7.2 Vetoquinol: Company Snapshot (2016)

          11.7.3 Strength of Product Portfolio

          11.7.4 Business Strategy Excellence

          11.7.5 Recent Developments

  11.8 Phibro Animal Health 

          11.8.1 Business Overview

          11.8.2 Phibro Animal Health: Company Snapshot (2016)

          11.8.3 Strength of Product Portfolio

          11.8.4 Business Strategy Excellence

          11.8.5 Recent Developments

  11.9 Hester 

          11.9.1 Business Overview

          11.9.2 Hester: Company Snapshot (2016)

          11.9.3 Strength of Product Portfolio

          11.9.4 Business Strategy Excellence

          11.9.5 Recent Developments

  11.10 Hipra 

          11.10.1 Business Overview

          11.10.2 Strength of Product Portfolio

          11.10.3 Business Strategy Excellence

          11.10.4 Recent Developments

  11.11 Idt Biologika 

          11.11.1 Business Overview

          11.11.2 Strength of Product Portfolio

          11.11.3 Business Strategy Excellence

          11.11.4 Recent Developments

  11.12 Biogenesis Bago 

          11.12.1 Business Overview

          11.12.2 Strength of Product Portfolio

          11.12.3 Business Strategy Excellence

  11.13 Tianjin Ringpu 

          11.13.1 Business Overview

          11.13.2 Strength of Product Portfolio

          11.13.3 Business Strategy Excellence

  11.14 China Animal Husbandry 

          11.14.1 Business Overview

          11.14.2 Strength of Product Portfolio

          11.14.3 Business Strategy Excellence

          11.14.4 Recent Developments

  11.15 Jinyu Bio-Technology 

          11.15.1 Business Overview

          11.15.2 Strength of Product Portfolio

          11.15.3 Business Strategy Excellence

 

Chapter 12 Research Finding and Conclusion 

 

Chapter 13  Research Methodology 

Chapter 14  Research Data Source 

Tables

Figures